Acadia Healthcare Company Inc (NASDAQ: ACHC) has a higher price-to-earnings ratio of 11.99x compared to its average ratio, The 36-month beta value for ACHC is at 0.88. Analysts have varying views on the stock, with 9 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ACHC is 89.38M, and currently, shorts hold a 10.41% of that float. The average trading volume for ACHC on July 10, 2025 was 2.57M shares.
ACHC) stock’s latest price update
The stock price of Acadia Healthcare Company Inc (NASDAQ: ACHC) has jumped by 1.24% compared to previous close of $24.12. Despite this, the company has seen a gain of 3.96% in its stock price over the last five trading days. seekingalpha.com reported 2025-07-05 that The Big Beautiful Bill boosts defense, industrials, and manufacturing, but healthcare and some REITs face headwinds from Medicaid cuts and policy shifts. AI optimism and the new legislation are fueling a broad market rally, but I question if AI stocks are outpacing their earnings, signaling a potential bubble. The Magnificent 7 era is over; META, MSFT, NVDA, and AMZN are the new leaders, while AAPL, GOOG, and TSLA face unique challenges in the AI race.
ACHC’s Market Performance
Acadia Healthcare Company Inc (ACHC) has experienced a 3.96% rise in stock performance for the past week, with a 7.39% rise in the past month, and a -7.57% drop in the past quarter. The volatility ratio for the week is 3.56%, and the volatility levels for the past 30 days are at 4.60% for ACHC. The simple moving average for the last 20 days is 9.59% for ACHC’s stock, with a simple moving average of -33.72% for the last 200 days.
Analysts’ Opinion of ACHC
Many brokerage firms have already submitted their reports for ACHC stocks, with Barclays repeating the rating for ACHC by listing it as a “Equal Weight.” The predicted price for ACHC in the upcoming period, according to Barclays is $35 based on the research report published on February 28, 2025 of the current year 2025.
KeyBanc Capital Markets, on the other hand, stated in their research note that they expect to see ACHC reach a price target of $70. The rating they have provided for ACHC stocks is “Overweight” according to the report published on January 07th, 2025.
Deutsche Bank gave a rating of “Buy” to ACHC, setting the target price at $75 in the report published on December 12th of the previous year.
ACHC Trading at 5.82% from the 50-Day Moving Average
After a stumble in the market that brought ACHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.37% of loss for the given period.
Stock Fundamentals for ACHC
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.63 for the gross margin
The net margin for Acadia Healthcare Company Inc stands at 0.06. The total capital return value is set at 0.07. Equity return is now at value 6.35, with 3.22 for asset returns.
Based on Acadia Healthcare Company Inc (ACHC), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is 3.44.
Currently, EBITDA for the company is 607.84 million with net debt to EBITDA at 4.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.42. The receivables turnover for the company is 7.96for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.35.
Conclusion
In conclusion, Acadia Healthcare Company Inc (ACHC) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
